MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
143.99%
Quick Ratio
135.50%
Cash Ratio
81.00%
Debt to Asset Ratio
55.70%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Operating lease right-of-use ass...
    • Prepaid expenses and other curre...
    • Research and development tax inc...
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, les...
    • Others
Balance Sheets
2026-06-30
2025-06-30
Cash and cash equivalents
3,992,312
1,019,909
Accounts receivable, net
848,464
594,614
Other current assets
-
826,976
Assets held for sale
-
327,500
Inventories, net
418,577
635,215
Research and development tax incentive receivable
806,951
734,408
Prepaid expenses and other current assets
1,030,932
-
Total current assets
7,097,236
4,138,622
Property and equipment, net
294,399
251,325
Operating lease right-of-use assets
1,751,040
69,520
Intangibles, net
2,799,161
3,790,319
Total assets
11,941,836
8,249,786
Accounts payable and accrued expenses
4,130,213
4,534,246
Current portion of operating lease liabilities
147,005
84,659
Notes payable
-
197,146
Current employee benefit liabilities
651,706
534,990
Deferred grant income
-
0
Total current liabilities
4,928,924
5,351,041
Employee benefit liabilities, less current portion
49,931
84,921
Operating lease liabilities, less current portion
1,672,155
0
Total liabilities
6,651,010
5,435,962
Common stock, 0.01 par value, 100,000,000 shares authorized, 2,905,615 and 2,905,603 shares issued and outstanding, as of june 30, 2026, respectively 732,339 and 732,327 shares issued and outstanding, as of june 30, 2025, respectively
29,056
73,230
Treasury stock, at cost, 12 shares as ofjune 30, 2026 and 2025, respectively
1
1
Additional paid-in capital
80,992,006
65,783,916
Accumulated deficit
-74,964,040
-62,533,065
Accumulated other comprehensive loss
-546,186
-327,944
Total consolidated intelligent bio solutions inc. equity
5,510,835
2,996,136
Non-controlling interest
-220,009
-182,312
Total shareholders equity
5,290,826
2,813,824
Total liabilities and shareholders equity
11,941,836
8,249,786
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$3,992,312 (291.44%↑ Y/Y)Prepaid expenses andother current assets$1,030,932 Accounts receivable, net$848,464 (42.69%↑ Y/Y)Research and developmenttax incentive...$806,951 (9.88%↑ Y/Y)Inventories, net$418,577 (-34.10%↓ Y/Y)Total current assets$7,097,236 (71.49%↑ Y/Y)Intangibles, net$2,799,161 (-26.15%↓ Y/Y)Operating leaseright-of-use assets$1,751,040 (2418.76%↑ Y/Y)Property and equipment,net$294,399 (17.14%↑ Y/Y)Total assets$11,941,836 (44.75%↑ Y/Y)Total liabilities andshareholders equity$11,941,836 (44.75%↑ Y/Y)Total liabilities$6,651,010 (22.35%↑ Y/Y)Total shareholdersequity$5,290,826 (88.03%↑ Y/Y)Non-controlling interest-$220,009 (-20.68%↓ Y/Y)Total currentliabilities$4,928,924 (-7.89%↓ Y/Y)Operating leaseliabilities, less current...$1,672,155 Employee benefitliabilities, less current...$49,931 (-41.20%↓ Y/Y)Total consolidatedintelligent bio solutions...$5,510,835 (83.93%↑ Y/Y)Accumulated deficit-$74,964,040 (-19.88%↓ Y/Y)Accumulated othercomprehensive loss-$546,186 (-66.55%↓ Y/Y)Treasury stock, at cost,12 shares as ofjune...$1 (0.00%↑ Y/Y)Accounts payable andaccrued expenses$4,130,213 (-8.91%↓ Y/Y)Current employeebenefit liabilities$651,706 (21.82%↑ Y/Y)Current portion ofoperating lease...$147,005 (73.64%↑ Y/Y)Additional paid-in capital$80,992,006 (23.12%↑ Y/Y)Common stock, 0.01 parvalue, 100,000,000...$29,056 (-60.32%↓ Y/Y)

INTELLIGENT BIO SOLUTIONS INC. (INBS)

INTELLIGENT BIO SOLUTIONS INC. (INBS)